# Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease

> **NCT00234702** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 84 (estimated)

## Conditions studied

- Kidney Diseases

## Interventions

- **DRUG:** Lanthanum carbonate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00234702
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01-11
- **Primary completion:** 2007-06-01
- **Final completion:** 2007-06-01
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234702, "Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00234702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*